The enlargement of medical and leisure marijuana legalization facilitates affected person entry to cannabis, and lots of sufferers with epilepsy pursue marijuana as a remedy for seizures. We administered a nine-item survey on marijuana use to sufferers seen in an epilepsy clinic over a 9 month interval at a tertiary care middle in Oregon the place leisure use was legalized in 2015. Nearly all of respondents (n = 39) reported cannabis use for the aim of treating epilepsy (87.2%, n = 34), and strongly agreed (53.8%, n = 21) or agreed (28.2%, n = 11) that cannabis use improved seizure management. Essentially the most generally chosen cannabis strains have been excessive cannabidiol (CBD) (30.8%, n = 12) or a number of varieties (30.8%, n = 12), with administration strategies of smoking (66.7%, n = 26), edibles (48.7%, n = 19), and concentrates (43.6%, n = 17). Extra members reported utilizing marijuana with primarily CBD than primarily tetrahydrocannabinol (THC) or equal CBD:THC content material, and only a few girls reported utilizing marijuana with primarily THC in contrast with males (10% of feminine versus 47% of male respondents). Solely 2 of 39 members have been in a position to give a precise dosage utilized in milligrams. Medical and leisure dispensaries have been the commonest cannabis sources, adopted by homegrown and pals/relations. Though pharmaceutical CBD extract is now Meals and Drug Administration (FDA)-approved for sure epilepsy varieties, entry stays restricted. Additional analysis is required to grasp leisure cannabis use amongst sufferers with epilepsy whereas scientific analysis for pharmaceutical cannabis merchandise continues.
Printed by Elsevier Inc.